User profiles for Wim Vos

Wim Vos

CEO, Radiomics
Verified email at radiomics.bio
Cited by 2978

[HTML][HTML] Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

…, EC Soer, J Verheij, APJ Vlaar, W Vos… - The Lancet …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple
organs and causes severe coagulopathy. Histopathological organ changes might not only …

A review in radiomics: making personalized medicine a reality via routine imaging

…, B Miraglio, S Walsh, W Vos… - Medicinal research …, 2022 - Wiley Online Library
Radiomics is the quantitative analysis of standard‐of‑care medical imaging; the information
obtained can be applied within clinical decision support systems to create diagnostic, …

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1

DF Dukers, P Meij, MBHJ Vervoort, W Vos… - The Journal of …, 2000 - journals.aai.org
In neoplastic cells of EBV-positive lymphoid malignancies latent membrane protein (LMP1)
is expressed. Because no adequate cellular immune response can be detected against …

Validation of computational fluid dynamics in CT-based airway models with SPECT/CT

JW De Backer, WG Vos, SC Vinchurkar, R Claes… - Radiology, 2010 - pubs.rsna.org
Purpose To compare the results obtained by using numerical flow simulations with the
results of combined single photon emission computed tomography (SPECT) and computed …

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

…, JM Clements, J Ford, KM Miller, R Pigott, W Vos… - Acta …, 1997 - Springer
The pathology of multiple sclerosis (MS) is characterised by breakdown of the blood-brain
barrier accompanied by infiltration of macrophages and T cells into the central nervous system …

[HTML][HTML] Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions

…, A Alberich-Bayarri, MI Menzel, S Walsh, W Vos… - Information …, 2022 - Elsevier
Removing the bias and variance of multicentre data has always been a challenge in large
scale digital healthcare studies, which requires the ability to integrate clinical features …

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T‐lymphocytes and preserved MHC class I …

…, BJR Sluijter, LM Moesbergen, WM Vos… - … journal of cancer, 2008 - Wiley Online Library
In this study we investigated whether the presence of specific populations of tumor infiltrating
lymphocytes (TILs) in diagnostic primary melanoma biopsies are related to outcome in …

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis

…, RQ Hintzen, GMGM Verjans, GP van Nierop, W Vos… - Brain, 2010 - academic.oup.com
SIR, Although recent studies have demonstrated a clear association of Epstein-Barr virus (EBV)
infection with multiple sclerosis (Zaadstra et al., 2008; Lunemann and Munz, 2009; …

Frequent overexpression of aurora B kinase, a novel drug target, in non–small cell lung carcinoma patients

B Vischioni, JJ Oudejans, W Vos, JA Rodriguez… - Molecular cancer …, 2006 - AACR
The serine/threonine protein kinase aurora B, a key regulator of mitosis, is emerging as a
novel drug target for cancer treatment. Aurora B overexpression has been previously …

Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma

…, JA Kummer, BA Bladergroen, W Vos… - Blood, The Journal …, 2002 - ashpublications.org
In vitro studies suggest that resistance to chemotherapy-induced apoptosis might explain
poor response to therapy in fatal cases. Actual execution of apoptosis depends on proper …